Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase NA 3Phase 3 3Phase 4 2Phase 1/2 1Phase 1 1

Status

Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 4Breast 3Genitourinary 2Sarcoma 1Lymphoid 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Breast Neoplasms 3Hot Flashes 1

Interventions

Cyclophosphamide 171Docetaxel 164Paclitaxel 160Trastuzumab 152Capecitabine 130Tamoxifen 119Letrozole 105Epirubicin 93Doxorubicin 83Anastrozole 83exemestane 77Fulvestrant 75Carboplatin 64Fluorouracil 63Radiotherapy 61pertuzumab 59Gemcitabine 55Vinorelbine 43Goserelin 39eribulin 36130-nm albumin-bound paclitaxel 36palbociclib 32Bevacizumab 32ribociclib 30Zoledronic Acid 29Lapatinib 29Methotrexate 28Drug Therapy 28Chemotherapy, Adjuvant 28Ado-Trastuzumab Emtansine 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Tablets × Breast × Clear all
NCT04055493 2026-05-11

ADAPTcycle

West German Study Group

Phase 3 Active not recruiting
1,684 enrolled
Breast

Breast Neoplasms

NCT06774885 2025-01-14

ROLE OF FOLIC ACID IN THE MANAGEMENT OF ADJUVANT ENDOCRINE THERAPY-INDUCED HOT FLASHES IN BREAST CANCER PATIENTS

Future University in Egypt

Phase 3 Not yet recruiting
120 enrolled
Breast

Breast Neoplasms, Hot Flashes

NCT04601116 2021-01-14

The MASTER Study (MAmmary Cancer STatin ER Positive Study)

Aarhus University Hospital

Phase 3 Recruiting
3,360 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡